Nortem Biogroup (XPAR:MLBIO) Scaled Net Operating Assets : 1.36 (As of Dec. 2022)

View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Nortem Biogroup's operating assets for the quarter that ended in Dec. 2022 was €13.30 Mil. Nortem Biogroup's operating liabilities for the quarter that ended in Dec. 2022 was €0.49 Mil. Nortem Biogroup's Total Assets for the quarter that ended in Dec. 2021 was €9.43 Mil. Therefore, Nortem Biogroup's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2022 was 1.36.

Nortem Biogroup Scaled Net Operating Assets Historical Data

The historical data trend for Nortem Biogroup's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup Scaled Net Operating Assets Chart

Nortem Biogroup Annual Data

Trend

Dec21

Dec22

Scaled Net Operating Assets

0.93

1.36

Nortem Biogroup Semi-Annual Data
	Dec21	Dec22
Scaled Net Operating Assets	0.93	1.36

Competitive Comparison of Nortem Biogroup's Scaled Net Operating Assets

For the Packaged Foods subindustry, Nortem Biogroup's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nortem Biogroup's Scaled Net Operating Assets Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Nortem Biogroup's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Nortem Biogroup's Scaled Net Operating Assets falls into.

Nortem Biogroup Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Nortem Biogroup's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2022 )
=	(Operating Assets (A: Dec. 2022 )	-	Operating Liabilities (A: Dec. 2022 ))	/	Total Assets (A: Dec. 2021 )
=	(13.303	-	0.491)	/	9.434
=	1.36

where

	Operating Assets		(A: Dec. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	13.468	-	0.165
=	13.303

	Operating Liabilities		(A: Dec. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	6.852	-	3.385	-	2.976
=	0.491

Nortem Biogroup's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2022 )
=	(Operating Assets (Q: Dec. 2022 )	-	Operating Liabilities (Q: Dec. 2022 ))	/	Total Assets (Q: Dec. 2021 )
=	(13.303	-	0.491)	/	9.434
=	1.36

where

	Operating Assets		(Q: Dec. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	13.468	-	0.165
=	13.303

	Operating Liabilities		(Q: Dec. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	6.852	-	3.385	-	2.976
=	0.491

Nortem Biogroup Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Nortem Biogroup (XPAR:MLBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500

Website

https://www.nortembiogroup.com

Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines